14 years of clinical drug development and clinical research experience in broad therapeutic areas with a consistent record of delivery within extremely high profile and pioneering programmes within the field of cancer, inflammation, respiratory, bone, cardiovascular and tobacco cessation studies. Excellent academic and research base, combined with the leadership ability to motivate large dispersed teams and drive exceptional performance. I have received numerous awards and accolades for the outstanding performance, including the ‘AstraZeneca Clinical Scholars Award’.

 

Qualification:

 

PhD Queen Mary University of London, (UK)

MD G. S. Medical College, Mumbai, (India)

MBBS MGI Medical Sciences (India)

 

Experience:

 

Medical Specialist: Respiratory studies, Novartis (UK)

Lead Clinician: Cardiovascular and Respiratory studies, Pfizer (UK)

Clinical Science Specialist, Clinical Development Inflammation, Roche (UK)

Trial Physician and Project lead, Cancer Research UK and Bart’s and London hospital (UK)

Physician and Project head, Breast and Cervical Study, Tata Memorial Cancer Hospital and research centre, India (India)

Lecturer, K J Somaiya Medical College and Research Centre, Mumbai, India

 

Publications:

 

Noon E, Singh S et. al. Significant differences in UK and US female bone density reference ranges. Osteoporos Int. 2010 Jan 9.

Mittra I et. al. A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening. Int J Cancer. 2010 Feb 15;126 (4):976-84.

Singh S et. al. Effect of baseline serum vitamin levels on aromatase inhibitor induced musculoskeletal symptoms: results from the chemoprevention study using anastrozole. Breast Cancer Res Treat. 2011Nov 10549-011-1911-6.